Your browser doesn't support javascript.
loading
High-Throughput Surface Plasmon Resonance Biosensors for Identifying Diverse Therapeutic Monoclonal Antibodies.
Matharu, Zimple; Bee, Christine; Schwarz, Flavio; Chen, Haibin; Tomlinson, Matthew; Wu, Gabriel; Rakestraw, Ginger; Hornsby, Michael; Drake, Andrew; Strop, Pavel; Rajpal, Arvind; Dollinger, Gavin.
Afiliación
  • Matharu Z; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Bee C; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Schwarz F; Frontier Medicines, South San Francisco, California 94080, United States.
  • Chen H; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Tomlinson M; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Wu G; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Rakestraw G; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Hornsby M; Bristol Myers Squibb, Cambridge, Massachusetts 02142, United States.
  • Drake A; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Strop P; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Rajpal A; Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, California 94063, United States.
  • Dollinger G; Biologics Discovery, Tallac Therapeutics, Burlingame, California 94010, United States.
Anal Chem ; 93(49): 16474-16480, 2021 12 14.
Article en En | MEDLINE | ID: mdl-34854675
Identification of antibodies targeting diverse functional epitopes on an antigen is highly crucial for discovering effective therapeutic candidates. Employing a traditional stepwise antibody "screening funnel" as well as prioritizing affinity-based selections over epitope-based selections, result in lead antibody panels lacking epitope diversity. In the present study, we employed an array-based surface plasmon resonance (SPR) platform to perform high-throughput epitope binning analysis on a large number of monoclonal antibodies (mAbs) generated in the early drug discovery process. The mAb panel contained clones from different antibody generation techniques and diverse transgenic mouse strains. The epitope binning results were analyzed in unique ways using various visualizations in the form of dendrograms and network plots, which assisted in determining diversity and redundancy in the mAb sample set. The binning data were further integrated with affinity information to evaluate the performance of seven different transgenic mouse strains. The combination of epitope binning results with binding kinetics and sequence analysis provided an effective and efficient way of selecting high affinity antibodies representing a diverse set of sequence families and epitopes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Límite: Animals Idioma: En Revista: Anal Chem Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antineoplásicos Inmunológicos / Anticuerpos Monoclonales Límite: Animals Idioma: En Revista: Anal Chem Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos